All Sauce from Weekly Sauce:

Wanderlust has become a strong incentive for Americans to get COVID-19 vaccines, a new study finds. The bucket list beckons, and “many people consider travel an essential part of their lifestyle and a contributor to their sense of well-being,” said study lead author Dogan Gursoy, a professor in hospitality business management at Washington State University.…  read on >  read on >

Never mind what the calendar says — your plants will tell you when spring is here. And even in Northern regions, they’re leafing out earlier than ever in recent decades due to climate change. In a new study, researchers attribute the early greening to two key factors: warmer temperatures and fewer rainy days. “This contrasting…  read on >  read on >

If there was something you could do to ward off Alzheimer’s disease, would you do it? If so, a new study has a suggestion: Get moving. Participants who were most physically fit were 33% less likely to develop Alzheimer’s disease than the least fit, the researchers found. And those whose fitness was below the most…  read on >  read on >

First-time moms and new mothers of twins may be among those at greatest risk of postpartum depression symptoms, a large new study suggests. Postpartum depression is a common illness. In the United States alone, about one in eight women report depression symptoms soon after giving birth, according to the U.S. Centers for Disease Control and…  read on >  read on >

People tend to have a specific image when they think of eating disorders — a disturbingly skinny white girl with reed-thin arms, her ribs and shoulder blades prominent. You don’t think of a ripped, beefy muscle man chugging a protein shake and fretting about carbs between weightlifting sessions. But maybe you should. Men and some…  read on >  read on >

As coronavirus cases across the United States drop, nearly half of the 500 million free COVID tests offered by the federal government have gone unused, according to the White House. It said Americans have placed 68 million orders for packages of four free rapid tests per family, but about 46% of the tests are still…  read on >  read on >

Settlements totaling $26 billion have been finalized between drugmaker Johnson & Johnson plus three major pharmaceutical distributors and state and local governments, over the companies’ role in America’s opioid crisis. The settlement plan — involving Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKesson — was first announced last year and is the largest to date…  read on >  read on >